Recombinant human activated protein C attenuates endotoxin-induced lung injury in awake sheep

[1]  J. Vincent,et al.  Beneficial effects of recombinant human activated protein C in a ewe model of septic shock* , 2007, Critical care medicine.

[2]  S. Willenbrock,et al.  Comparison of the human and canine cytokines IL-1(alpha/beta) and TNF-alpha to orthologous other mammalians. , 2007, The Journal of heredity.

[3]  V. Kuzkov,et al.  Extravascular lung water after pneumonectomy and one-lung ventilation in sheep , 2007, Critical care medicine.

[4]  J. Fraser,et al.  Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis , 2006, Critical care medicine.

[5]  M. Astiz,et al.  Effect of recombinant activated protein C and low-dose heparin on neutrophil-endothelial cell interactions in septic shock* , 2006, Critical care medicine.

[6]  G. Bernard,et al.  Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome , 2006, Critical care.

[7]  A. Groeneveld,et al.  Extravascular lung water to blood volume ratios as measures of permeability in sepsis-induced ALI/ARDS , 2006, Intensive Care Medicine.

[8]  V. Kuzkov,et al.  Extravascular lung water determined with single transpulmonary thermodilution correlates with the severity of sepsis-induced acute lung injury , 2006, Critical care medicine.

[9]  C. Feistritzer,et al.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.

[10]  M. Kirov,et al.  Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C , 2005, Critical care.

[11]  A. Artigas,et al.  Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination , 1994, Intensive Care Medicine.

[12]  Jerry A Nick,et al.  Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. , 2004, Blood.

[13]  D. Nelson,et al.  Leukocyte and endothelial cell interactions in sepsis: Relevance of the protein C pathway , 2004, Critical care medicine.

[14]  O. V. Evgenov,et al.  Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep , 2004, Critical care medicine.

[15]  M. Matějovič,et al.  Fluid challenge in patients at risk for fluid loading‐induced pulmonary edema , 2004, Acta anaesthesiologica Scandinavica.

[16]  A. Verin,et al.  Molecular Mechanisms of Thrombin-Induced Endothelial Cell Permeability , 2004, Biochemistry (Moscow).

[17]  M. Matthay,et al.  Protein C and thrombomodulin in human acute lung injury. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[18]  M. Carraway,et al.  Blockade of tissue factor: treatment for organ injury in established sepsis. , 2003, American journal of respiratory and critical care medicine.

[19]  G. Bernard,et al.  Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial* , 2003, Critical care medicine.

[20]  O. Kemmotsu,et al.  Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. , 2003, Thrombosis research.

[21]  C. Esmon,et al.  The protein C pathway , 2000, Chest.

[22]  D. Morel,et al.  Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model , 2002, Critical care medicine.

[23]  S. Horiuchi,et al.  Activated Protein C Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production by Inhibiting Activation of both Nuclear Factor-κB and Activator Protein-1 in Human Monocytes , 2002, Thrombosis and Haemostasis.

[24]  S. Horiuchi,et al.  Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. , 2002, Thrombosis and haemostasis.

[25]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[26]  Z. H. Zhou,et al.  Prevention of rabbit acute lung injury by surfactant, inhaled nitric oxide, and pressure support ventilation. , 2000, American journal of respiratory and critical care medicine.

[27]  K. Reinhart,et al.  Treating patients with severe sepsis. , 1999, The New England journal of medicine.

[28]  J. Newman,et al.  Inhaled nitric oxide reduces lung fluid filtration after endotoxin in awake sheep. , 1998, American journal of respiratory and critical care medicine.

[29]  K. Takatsuki,et al.  Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. , 1997, The American journal of physiology.

[30]  T. Elsasser,et al.  TNF-alpha and the pathophysiology of endotoxin-induced acute respiratory failure in sheep. , 1996, Journal of applied physiology.

[31]  K. Takatsuki,et al.  Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. , 1996, Blood.

[32]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[33]  J. Pittet,et al.  Time course of plasma and pulmonary lymph endothelin-like immunoreactivity during sustained endotoxaemia in chronically instrumented sheep. , 1991, Clinical science.

[34]  R. Tompkins,et al.  Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. , 1990, The Journal of infectious diseases.

[35]  A. Chang,et al.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. , 1987, The Journal of clinical investigation.

[36]  K. Brigham,et al.  Influence of steroidal and nonsteroidal anti-inflammatory agents on the accumulation of arachidonic acid metabolites in plasma and lung lymph after endotoxemia in awake sheep. Measurements of prostacyclin and thromboxane metabolites and 12-HETE. , 2015, The American review of respiratory disease.

[37]  G. Bernard,et al.  Endotoxemia-induced leukopenia in sheep. Correlation with lung vascular permeability and hypoxemia but not with pulmonary hypertension. , 1983, The American review of respiratory disease.

[38]  J. Newman,et al.  Respiratory failure after endotoxin infusion in sheep: lung mechanics and lung fluid balance. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[39]  K. Brigham,et al.  Increased Sheep Lung Vascular Permeability Caused by Escherichia coli Endotoxin , 1979, Circulation research.